TY  - BOOK
AU  - Hala Tarek Fathi
AU  - Asmaa Ahmed Abdelaal , 
AU  - Laila Abdelrahman M. Hegazy , 
AU  - Sara Adal Labib , 
TI  - Prame and rhamm genes expression in acute myeloid leukemia / 
PY  - 2013///
CY  - Cairo : 
PB  - Hala Tarek Fathi , 
KW  - Acute myeloid leukemia
KW  - Prame (preferentially expressed antigen of melanoma
KW  - Tumor/leukemia associated antigens TAAs/LAAs
N1  - Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology; Issued also as CD
N2  - Most patients with acute myeloid leukemia who are younger than 60 years achieve complete remission after chemotherapy and / or SCT. However relapse with its high associated morbidity and mortality (5 years survival rate 50% ) still occurs. To improve the clinical outcome of AML patients leukemia associated antigens were suggested to be targets for immune therapies as an additional approach to chemotherapy and / or SCT
ER  -